Characterization of resident B cells of vascular walls in human atherosclerotic patients

Journal of Immunology

Volumn 191, Issue 6, 2013, Pages 3006-3016

  Hamze, Moustafa ^a   Desmetz, Caroline ^a   Berthe, Marie Laurence ^b   Roger, Pascal ^c,d   Boulle, Nathalie ^b,e   Brancherau, Pascal ^c   Picard, Eric ^c   Guzman, Caroline ^a   Tolza, Claire ^a   Guglielmi, Paul ^a  

^a CNRS   (France)

^b HÔPITAL ARNAUD DE VILLENEUVE   (France)

^c DEPARTMENT OF NEUROLOGY   (France)

^d UNIV MONTPELLIER   (France)

^e INSTITUT DE RECHERCHE EN CANCÉROLOGIE DE MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; CD20 ANTIGEN; COLONY STIMULATING FACTOR 1; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; SYNDECAN 1; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ADVENTITIA; AGED; ARTERY WALL; ARTICLE; ATHEROMA; ATHEROSCLEROSIS; B LYMPHOCYTE; BLOOD VESSEL WALL; CAROTID ENDARTERECTOMY; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; HEAVY CHAIN; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOGLOBULIN PRODUCTION; LASER CAPTURE MICRODISSECTION; LYMPH NODE; LYMPHOCYTE RECIRCULATION; MALE; MONONUCLEAR CELL; PATHOPHYSIOLOGY; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; B-LYMPHOCYTES; CAROTID ARTERIES; CAROTID ARTERY DISEASES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84884223962     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202870     Document Type: Article

References (72)

1. Weber, C., A. Zernecke, and P. Libby. 2008. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat. Rev. Immunol. 8: 802-815.
2. Smith, J. D., E. Trogan, M. Ginsberg, C. Grigaux, J. Tian, and M. Miyata. 1995. Decreased atherosclerosis in mice deficient in both macrophage colonystimulating factor (op) and apolipoprotein E. Proc. Natl. Acad. Sci. USA 92: 8264-8268.
3. Hansson, G. K., and A. Hermansson. 2011. The immune system in atherosclerosis. Nat. Immunol. 12: 204-212.
4. Mallat, Z., A. Gojova, V. Brun, B. Esposito, N. Fournier, F. Cottrez, A. Tedgui, and H. Groux. 2003. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation 108: 1232-1237.
5. Ait-Oufella, H., O. Herbin, J.-D. Bouaziz, C. J. Binder, C. Uyttenhove, L. Laurans, S. Taleb, E. Van Vré, B. Esposito, J. Vilar, et al. 2010. B cell depletion reduces the development of atherosclerosis in mice. J. Exp. Med. 207: 1579-1587.
6. Kyaw, T., C. Tay, A. Khan, V. Dumouchel, A. Cao, K. To, M. Kehry, R. Dunn, A. Agrotis, P. Tipping, et al. 2010. Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis. J. Immunol. 185: 4410-4419.
7. Galkina, E., A. Kadl, J. Sanders, D. Varughese, I. J. Sarembock, and K. Ley. 2006. Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J. Exp. Med. 203: 1273-1282.
8. Jonasson, L., J. Holm, O. Skalli, G. Bondjers, and G. K. Hansson. 1986. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 6: 131-138.
9. Munro, J. M., J. D. van der Walt, C. S. Munro, J. A. C. Chalmers, and E. L. Cox. 1987. An immunohistochemical analysis of human aortic fatty streaks. Hum. Pathol. 18: 375-380.
10. Walton, L. J., J. T. Powell, and D. V. Parums. 1997. Unrestricted usage of immunoglobulin heavy chain genes in B cells infiltrating the wall of atherosclerotic abdominal aortic aneurysms. Atherosclerosis 135: 65-71.
11. Houtkamp, M. A., O. J. de Boer, C. M. van der Loos, A. C. van der Wal, and A. E. Becker. 2001. Adventitial infiltrates associated with advanced atherosclerotic plaques: structural organization suggests generation of local humoral immune responses. J. Pathol. 193: 263-269.
12. Moos, M. P. W., N. John, R. Gräbner, S. Nossmann, B. Günther, R. Vollandt, C. D. Funk, B. Kaiser, and A. J. R. Habenicht. 2005. The lamina adventitia is the major site of immune cell accumulation in standard chow-fed apolipoprotein Edeficient mice. Arterioscler. Thromb. Vasc. Biol. 25: 2386-2391.
13. Watanabe, M., A. Sangawa, Y. Sasaki, M. Yamashita, M. Tanaka-Shintani, M. Shintaku, and Y. Ishikawa. 2007. Distribution of inflammatory cells in adventitia changed with advancing atherosclerosis of human coronary artery. J. Atheroscler. Thromb. 14: 325-331.
14. Aubry, M. C., D. L. Riehle, W. D. Edwards, H. Maradit-Kremers, V. L. Roger, T. J. Sebo, and S. E. Gabriel. 2004. B-Lymphocytes in plaque and adventitia of coronary arteries in two patients with rheumatoid arthritis and coronary atherosclerosis: preliminary observations. Cardiovasc. Pathol. 13: 233-236.
15. Gräbner, R., K. Lötzer, S. Döpping, M. Hildner, D. Radke, M. Beer, R. Spanbroek, B. Lippert, C. A. Reardon, G. S. Getz, et al. 2009. Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/-mice. J. Exp. Med. 206: 233-248.
16. Major, A. S., S. Fazio, and M. F. Linton. 2002. B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arterioscler. Thromb. Vasc. Biol. 22: 1892-1898.
17. Caligiuri, G., A. Nicoletti, B. Poirier, and G. K. Hansson. 2002. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J. Clin. Invest. 109: 745-753.
18. Binder, C. J., K. Hartvigsen, M. K. Chang, M. Miller, D. Broide, W. Palinski, L. K. Curtiss, M. Corr, and J. L. Witztum. 2004. IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J. Clin. Invest. 114: 427-437.
19. Palinski, W., E. Miller, and J. L. Witztum. 1995. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehydemodified LDL reduces atherogenesis. Proc. Natl. Acad. Sci. USA 92: 821-825.
20. Zhou, X. H., G. Caligiuri, A. Hamsten, A. K. Lefvert, and G. K. Hansson. 2001. LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 21: 108-114.
21. Palinski, W., R. K. Tangirala, E. Miller, S. G. Young, and J. L. Witztum. 1995. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptordeficient mice with increased atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 15: 1569-1576.
22. Cyrus, T., D. Praticò, L. Zhao, J. L. Witztum, D. J. Rader, J. Rokach, G. A. FitzGerald, and C. D. Funk. 2001. Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein e-deficient mice. Circulation 103: 2277-2282.
23. Tsimikas, S., W. Palinski, and J. L. Witztum. 2001. Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 21: 95-100.
24. Rossi, G. P., M. Cesari, R. De Toni, M. Zanchetta, G. Maiolino, L. Pedon, C. Ganzaroli, P. Maiolino, and A. C. Pessina. 2003. Antibodies to oxidized lowdensity lipoproteins and angiographically assessed coronary artery disease in white patients. Circulation 108: 2467-2472.
25. Tsimikas, S., E. S. Brilakis, R. J. Lennon, E. R. Miller, J. L. Witztum, J. P. McConnell, K. S. Kornman, and P. B. Berger. 2007. Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events. J. Lipid Res. 48: 425-433.
26. Kyaw, T., C. Tay, S. Krishnamurthi, P. Kanellakis, A. Agrotis, P. Tipping, A. Bobik, and B.-H. Toh. 2011. B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions. Circ. Res. 109: 830-840.
27. Kyaw, T., P. Tipping, B.-H. Toh, and A. Bobik. 2011. Current understanding of the role of B cell subsets and intimal and adventitial B cells in atherosclerosis. Curr. Opin. Lipidol. 22: 373-379.
28. Doran, A. C., M. J. Lipinski, S. N. Oldham, J. C. Garmey, K. A. Campbell, M. D. Skaflen, A. Cutchins, D. J. Lee, D. K. Glover, K. A. Kelly, et al. 2012. B-cell aortic homing and atheroprotection depend on Id3. Circ. Res. 110: e1-12. doi: 10.1161.
29. Delfour, C., P. Roger, C. Bret, M. L. Berthe, P. Rochaix, N. Kalfa, P. Raynaud, F. Bibeau, T. Maudelonde, and N. Boulle. 2006. RCL2, a new fixative, preserves morphology and nucleic acid integrity in paraffin-embedded breast carcinoma and microdissected breast tumor cells. J. Mol. Diagn. 8: 157-169.
30. Masir, N., M. Ghoddoosi, S. Mansor, F. Abdul-Rahman, C. S. Florence, N. A. Mohamed-Ismail, M.-R. Tamby, and N. H. Md-Latar. 2012. RCL2, a potential formalin substitute for tissue fixation in routine pathological specimens. Histopathology 60: 804-815.
31. Lefranc, M.-P., V. Giudicelli, C. Ginestoux, J. Jabado-Michaloud, G. Folch, F. Bellahcene, Y. Wu, E. Gemrot, X. Brochet, J. Lane, et al. 2009. IMGT (R), the international ImMunoGeneTics information system (R). Nucleic Acids Res. 37: D1006-D10012. doi: 10.1093.
32. Glanville, J., W. Zhai, J. Berka, D. Telman, G. Huerta, G. R. Mehta, I. Ni, L. Mei, P. D. Sundar, G. M. R. Day, et al. 2009. Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire. Proc. Natl. Acad. Sci. USA 106: 20216-20221.
33. Zhou, X., and G. K. Hansson. 1999. Detection of B cells and proinflammatory cytokines in atherosclerotic plaques of hypercholesterolaemic apolipoprotein E knockout mice. Scand. J. Immunol. 50: 25-30.
34. Katsuda, S., H. C. Boyd, C. Fligner, R. Ross, and A. M. Gown. 1992. Human atherosclerosis. III. Immunocytochemical analysis of the cell composition of lesions of young adults. Am. J. Pathol. 140: 907-914.
35. Gerlis, L. M. 1956. The significance of adventitial infiltrations in coronary atherosclerosis. Br. Heart J. 18: 166-172.
36. Schwartz, C. J., and J. R. Mitchell. 1962. Cellular infiltration of the human arterial adventitia associated with atheromatous plaques. Circulation 26: 73-78.
37. Muscari, A., C. Bozzoli, C. Gerratana, F. Zaca', C. Rovinetti, D. Zauli, M. La Placa, and P. Puddu. 1988. Association of serum IgA and C4 with severe atherosclerosis. Atherosclerosis 74: 179-186.
38. Kett, K., P. Brandtzaeg, J. Radl, and J. J. Haaijman. 1986. Different subclass distribution of IgA-producing cells in human lymphoid organs and various secretory tissues. J. Immunol. 136: 3631-3635.
39. Stavnezer, J., and C. T. Amemiya. 2004. Evolution of isotype switching. Semin. Immunol. 16: 257-275.
40. Vlaicu, R., H. G. Rus, F. Niculescu, and A. Cristea. 1985. Immunoglobulins and complement components in human aortic atherosclerotic intima. Atherosclerosis 55: 35-50.
41. Hollander, W., M. A. Colombo, B. Kirkpatrick, and J. Paddock. 1979. Soluble proteins in the human atherosclerotic plaque. With spectral reference to immunoglobulins, C3-complement component, alpha 1-antitrypsin and alpha 2-macroglobulin. Atherosclerosis 34: 391-405.
42. Lewis, M. J., T. H. Malik, M. R. Ehrenstein, J. J. Boyle, M. Botto, and D. O. Haskard. 2009. Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 120: 417-426.
43. Yla-Herttuala, S., W. Palinski, S. W. Butler, S. Picard, D. Steinberg, and J. L. Witztum. 1994. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler. Thromb. 14: 32-40.
44. Burioni, R., F. Canducci, D. Saita, M. Perotti, N. Mancini, D. De Marco, N. Clementi, A. Chieffo, M. Denaro, D. Cianflone, et al. 2009. Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques. J. Immunol. 183: 2537-2544.
45. Stemme, S., L. Rymo, and G. K. Hansson. 1991. Polyclonal origin of T lymphocytes in human atherosclerotic plaques. Lab. Invest. 65: 654-660.
46. Swanson, S. J., A. Rosenzweig, J. G. Seidman, and P. Libby. 1994. Diversity of T-cell antigen receptor V beta gene utilization in advanced human atheroma. Arterioscler. Thromb. 14: 1210-1214.
47. Paulsson, G., X. H. Zhou, E. Törnquist, and G. K. Hansson. 2000. Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 20: 10-17.
48. Rossmann, A., B. Henderson, B. Heidecker, R. Seiler, G. Fraedrich, M. Singh, W. Parson, M. Keller, B. Grubeck-Loebenstein, and G. Wick. 2008. T-cells from advanced atherosclerotic lesions recognize hHSP60 and have a restricted T-cell receptor repertoire. Exp. Gerontol. 43: 229-237.
49. Oracki, S. A., J. A. Walker, M. L. Hibbs, L. M. Corcoran, and D. M. Tarlinton. 2010. Plasma cell development and survival. Immunol. Rev. 237: 140-159.
50. Canducci, F., D. Saita, C. Foglieni, M.R. Piscopiello, R. Chiesa, A. Colombo, D. Cianflone, A. Maseri, M. Clementi, and R. Burioni. 2012. Cross-reacting antibacterial auto-antibodies are produced within coronary atherosclerotic plaques of acute coronary syndrome patients. PLoS One 7: e42283. doi: 10.1371.
51. Zhu, S.-N., M. Chen, J. Jongstra-Bilen, and M. I. Cybulsky. 2009. GM-CSF regulates intimal cell proliferation in nascent atherosclerotic lesions. J. Exp. Med. 206: 2141-2149.
52. Mantovani, A., A. Sica, and M. Locati. 2007. New vistas on macrophage differentiation and activation. Eur. J. Immunol. 37: 14-16.
53. Brochériou, I., S. Maouche, H. Durand, V. Braunersreuther, G. Le Naour, A. Gratchev, F. Koskas, F. Mach, J. Kzhyshkowska, and E. Ninio. 2011. Antagonistic regulation of macrophage phenotype by M-CSF and GM-CSF: implication in atherosclerosis. Atherosclerosis 214: 316-324.
54. Peters, A., Y. Lee, and V. K. Kuchroo. 2011. The many faces of Th17 cells. Curr. Opin. Immunol. 23: 702-706.
55. Harris, T. B., L. Ferrucci, R. P. Tracy, M. C. Corti, S. Wacholder, W. H. Ettinger, Jr., H. Heimovitz, H. J. Cohen, and R. Wallace. 1999. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am. J. Med. 106: 506-512.
56. Skoog, T., W. Dichtl, S. Boquist, C. Skoglund-Andersson, F. Karpe, R. Tang, M. G. Bond, U. de Faire, J. Nilsson, P. Eriksson, and A. Hamsten. 2002. Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middleaged men. Eur. Heart J. 23: 376-383.
57. Huber, S. A., P. Sakkinen, D. Conze, N. Hardin, and R. Tracy. 1999. Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 19: 2364-2367.
58. Schieffer, B., T. Selle, A. Hilfiker, D. Hilfiker-Kleiner, K. Grote, U. J. F. Tietge, C. Trautwein, M. Luchtefeld, C. Schmittkamp, S. Heeneman, et al. 2004. Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis. Circulation 110: 3493-3500.
59. Ohta, H., H. Wada, T. Niwa, H. Kirii, N. Iwamoto, H. Fujii, K. Saito, K. Sekikawa, and M. Seishima. 2005. Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice. Atherosclerosis 180: 11-17.
60. Schreyer, S. A., C. M. Vick, and R. C. LeBoeuf. 2002. Loss of lymphotoxinalpha but not tumor necrosis factor-alpha reduces atherosclerosis in mice. J. Biol. Chem. 277: 12364-12368.
61. Schreyer, S. A., J. J. Peschon, and R. C. LeBoeuf. 1996. Accelerated atherosclerosis in mice lacking tumor necrosis factor receptor p55. J. Biol. Chem. 271: 26174-26178.
62. Shaposhnik, Z., X. Wang, M. Weinstein, B. J. Bennett, and A. J. Lusis. 2007. Granulocyte macrophage colony-stimulating factor regulates dendritic cell content of atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 27: 621-627.
63. Ditiatkovski, M., B.-H. Toh, and A. Bobik. 2006. GM-CSF deficiency reduces macrophage PPAR-gamma expression and aggravates atherosclerosis in ApoEdeficient mice. Arterioscler. Thromb. Vasc. Biol. 26: 2337-2344.
64. Haghighat, A., D. Weiss, M. K. Whalin, D. P. Cowan, and W. R. Taylor. 2007. Granulocyte colony-stimulating factor and granulocyte macrophage colonystimulating factor exacerbate atherosclerosis in apolipoprotein E-deficient mice. Circulation 115: 2049-2054.
65. Barr, T. A., P. Shen, S. Brown, V. Lampropoulou, T. Roch, S. Lawrie, B. Fan, R. A. O'Connor, S. M. Anderton, A. Bar-Or, et al. 2012. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J. Exp. Med. 209: 1001-1010.
66. Harris, D. P., L. Haynes, P. C. Sayles, D. K. Duso, S. M. Eaton, N. M. Lepak, L. L. Johnson, S. L. Swain, and F. E. Lund. 2000. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat. Immunol. 1: 475-482.
67. Burdin, N., C. Van Kooten, L. Galibert, J. S. Abrams, J.Wijdenes, J. Banchereau, and F. Rousset. 1995. Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes. J. Immunol. 154: 2533-2544.
68. Motallebzadeh, R., S. Rehakova, T. M. Conlon, T. S. Win, C. J. Callaghan, M. Goddard, E. M. Bolton, N. H. Ruddle, J. A. Bradley, and G. J. Pettigrew. 2012. Blocking lymphotoxin signaling abrogates the development of ectopic lymphoid tissue within cardiac allografts and inhibits effector antibody responses. FASEB J. 26: 51-62.
69. Segerer, S., and D. Schlöndorff. 2008. B cells and tertiary lymphoid organs in renal inflammation. Kidney Int. 73: 533-537.
70. Heller, F., M. T. Lindenmeyer, C. D. Cohen, U. Brandt, D. Draganovici, M. Fischereder, M. Kretzler, H.-J. Anders, T. Sitter, I. Mosberger, et al. 2007. The contribution of B cells to renal interstitial inflammation. Am. J. Pathol. 170: 457-468.
71. Nikolajczyk, B. S. 2010. B cells as under-appreciated mediators of non-autoimmune inflammatory disease. Cytokine 50: 234-242.
72. Winer, D. A., S. Winer, L. Shen, P. P. Wadia, J. Yantha, G. Paltser, H. Tsui, P. Wu, M. G. Davidson, M. N. Alonso, et al. 2011. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat. Med. 17: 610-617.